HOME >> BIOLOGY >> NEWS
Use Of Protease Inhibitors For HIV Associated With Dramatic Rise In Oral Warts

espond to treatment, and Kaposi's sarcoma is now much rarer, Greenspan explains.

Incidence of all three oral conditions declined significantly year by year during the study period, the researchers found. In contrast, the incidence of oral warts increased dramatically from 1996-98, the period during which protease inhibitor treatments became more common.

The study examined the incidence of oral warts among those who were treated with protease inhibitors and other advanced antiretroviral (ARV) therapies, as well as those undergoing ARV treatment other than protease inhibitors. Finally, it compared both these groups with those not treated with any ARV therapy. Results showed that protease inhibitors specifically are associated with the great increase in oral warts, according to Greenspan.

"We have an apparently paradoxical increase in oral human HPV warts which appears to be an...unexpected complication of HAART," the researchers conclude. The increases in oral warts and decreases in the other three conditions were highly significant statistically, according to study

The UCSF team includes John Greenspan, BDS, PhD, director of the Oral AIDS Center and the AIDS Clinical Research Center, and chair of the stomatology department; Alison Canchola, MS, statistician for the Oral AIDS Center; Laurie MacPhail, PhD, DMD, associate clinical professor of stomatology; Behnaz Cheikh, DDS, a Fellow in stomatology; Herve Sroussi, DDS, postdoctoral scientist in stomatology; Joel Palefsky, MD, associate professor of laboratory medicine; and Joan Hilton, ScD, associate professor of epidemiology and biostatistics.


'"/>

Contact: Wallace Ravven
wravven@itsa.ucsf.edu
415-476-2557
University of California - San Francisco
5-Feb-1999


Page: 1 2

Related biology news :

1. Protease-inhibitor cocktail protects, increases anti-microbial action of promising new peptide
2. Phase III Results Suggest Potent Antiviral Activity For Vertex And Glaxo Wellcomes Second-Generation HIV Protease Inhibitor Agenerase TM
3. New Class Of Protease Inhibitors May Be Effective In Treating One Of Latin Americas Most Devastating Diseases
4. HIV-Positive Injection Drug Users Often Dont Receive Protease Inhibitors And May Not Be Aware Of The Drug
5. Researchers Document Transmission Of Protease-Resistant HIV
6. How Super Are The "Super Aspirins"? -- New COX-2 Inhibitors May Elevate Cardiovascular Risk
7. Cholesterol Inhibitors In Garlic Identified
8. Researchers Find Protein Abnormality Associated With Alzheimers Disease
9. Risks For Heart Disease Associated With Size Of LDL Particles
10. Bacteria From Gum Infections Associated With Diabetes, Chronic Lung Disease, UB Studies Find
11. Variations In The Human Homologue Of A Fruit Fly Gene Are Associated With Mood And Panic Disorders

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... , ... July 01, 2020 , ... ... its phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory ... 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer ...
(Date:6/28/2020)... Switzerland (PRWEB) , ... June ... ... provider of enterprise software solutions for biopharmaceutical R&D, today announced that it ... company developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and ...
(Date:6/23/2020)... , ... June 23, 2020 , ... ... sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative portable ... support testing operations in the fight against the COVID-19 pandemic in Zambia. , ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... 23, 2020 , ... Kerafast Inc. , developers of ... the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, ... SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., announced today ... 22-24 during the American Association for Cancer Research Virtual meeting. One poster describes ... consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
(Date:6/11/2020)... ... , ... Greffex, a leading genetic engineering company, with the ... vectors, recently announced a key manufacturing agreement with FUJIFILM Diosynth Biotechnologies to produce ... successful gene therapy delivery vehicle (vector) with broad applications for delivering treatments including ...
(Date:6/11/2020)... ... 2020 , ... Reducing carbon emissions has been and will continue to be ... market dips, ways to reduce CO2 is something we can’t avoid. , To ... biofuels being produced today are created from recycled cooking oil or crops. Unfortunately, these ...
Breaking Biology Technology:
Cached News: